![PDF) Microglia control the spread of neurotropic virus infection via P2Y12 signalling and recruit monocytes through P2Y12-independent mechanisms PDF) Microglia control the spread of neurotropic virus infection via P2Y12 signalling and recruit monocytes through P2Y12-independent mechanisms](https://i1.rgstatic.net/publication/326503349_Microglia_control_the_spread_of_neurotropic_virus_infection_via_P2Y12_signalling_and_recruit_monocytes_through_P2Y12-independent_mechanisms/links/5fb7ce2c458515b7975616a0/largepreview.png)
PDF) Microglia control the spread of neurotropic virus infection via P2Y12 signalling and recruit monocytes through P2Y12-independent mechanisms
![Frontiers | Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: Frontiers | Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls:](https://www.frontiersin.org/files/Articles/846248/fimmu-13-846248-HTML/image_m/fimmu-13-846248-g001.jpg)
Frontiers | Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls:
![PDF) Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A PDF) Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A](https://i1.rgstatic.net/publication/359634733_Humoral_and_Cellular_Immunogenicity_and_Safety_of_Five_Different_SARS-CoV-2_Vaccines_in_Patients_With_Autoimmune_Rheumatic_and_Musculoskeletal_Diseases_in_Remission_or_With_Low_Disease_Activity_and_in/links/6246163c8068956f3c5c7935/largepreview.png)
PDF) Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A
![alpha-thema: Licht und Dunkel: Deutschland bei Nacht | Fernsehen | BR-KLASSIK | Bayerischer Rundfunk alpha-thema: Licht und Dunkel: Deutschland bei Nacht | Fernsehen | BR-KLASSIK | Bayerischer Rundfunk](https://www.br-klassik.de/programm/fernsehen/broadcastimage-150344~_h-272_v-img__16__9__xl_w-483_-d14a9968b6314b64cbfb1fbee8edfee50e8c00e5.jpg?version=29780)